CHF329.60
1.38% yesterday
SIX Swiss Exchange, Dec 23, 05:31 pm CET
ISIN
CH0012032048
Symbol
ROG
Index

Roche Stock price

CHF329.60
+18.70 6.01% 1M
+69.10 26.53% 6M
+74.10 29.00% YTD
+78.60 31.31% 1Y
+34.40 11.65% 3Y
+28.10 9.32% 5Y
+57.10 20.95% 10Y
+135.20 69.55% 20Y
SIX Swiss Exchange, Closing price Tue, Dec 23 2025
+4.50 1.38%
ISIN
CH0012032048
Symbol
ROG
Index
Industry

New AI Insights on Roche Insights AI Insights on Roche

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
CHF259.9b
Enterprise Value
CHF280.9b
Net debt
CHF21.0b
Cash
CHF12.0b
Shares outstanding
796.3m
Valuation (TTM | estimate)
P/E
28.1 | 16.6
P/S
4.2 | 4.1
EV/Sales
4.6 | 4.5
EV/FCF
21.3
P/B
9.1
Dividends
DPS
CHF9.70
Yield 1Y | 5Y
2.9% | 3.1%
Growth 1Y | 5Y
1.0% | 1.5%
Payout 1Y | 3Y
94.0% | 72.0%
Increased
25 Years
Financials (TTM | estimate)
Revenue
CHF61.6b | CHF62.9b
EBITDA
CHF21.1b | CHF24.7b
EBIT
CHF20.8b | CHF21.3b
Net Income
CHF9.4b | CHF15.8b
Free Cash Flow
CHF13.2b
Growth (TTM | estimate)
Revenue
4.8% | 4.0%
EBITDA
9.7% | 20.7%
EBIT
10.0% | 5.9%
Net Income
-11.2% | 91.0%
Free Cash Flow
16.4%
Margin (TTM | estimate)
Gross
73.9%
EBITDA
34.3% | 39.2%
EBIT
33.8%
Net
15.3% | 25.1%
Free Cash Flow
21.4%
Financial Health
Equity Ratio
31.2%
Return on Equity
26.1%
ROCE
31.0%
ROIC
26.5%
Debt/Equity
1.2
More
EPS
CHF11.8
FCF per Share
CHF16.6
Short interest
-
Employees
103k
Rev per Employee
CHF590.0k
Show more

Create a Free Account to create an Roche alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Roche Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Roche forecast:

14x Buy
52%
8x Hold
30%
5x Sell
19%

Analyst Opinions

27 Analysts have issued a Roche forecast:

Buy
52%
Hold
30%
Sell
19%

Financial data from Roche

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
61,591 61,591
5% 5%
100%
- Direct Costs 16,060 16,060
4% 4%
26%
45,531 45,531
5% 5%
74%
- Selling and Administrative Expenses 13,890 13,890
4% 4%
23%
- Research and Development Expense 12,848 12,848
2% 2%
21%
21,140 21,140
10% 10%
34%
- Depreciation and Amortization 329 329
6% 6%
1%
EBIT (Operating Income) EBIT 20,811 20,811
10% 10%
34%
Net Profit 9,429 9,429
11% 11%
15%

In millions CHF.

Don't miss a Thing! We will send you all news about Roche directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Roche Stock News

Neutral
Business Wire
2 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELO™ (mosunetuzumab-axgb), as a subcutaneous (SC) formulation, for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or mor...
Negative
Reuters
4 days ago
Deals between pharmaceutical companies and Washington to reduce prices for medicines in the United States will likely push up the cost of new drugs in Switzerland, the CEO of Swiss pharma giant Roche was quoted as saying on Saturday.
Neutral
WSJ
5 days ago
The companies, including Bristol-Myers Squibb, GSK and Merck, would avoid potential U.S. tariffs in return.
More Roche News

Company Profile

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Thomas Schinecker
Employees 103,249
Founded 1896
Website www.roche.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today